Market closedNon-fractional
Bioventus/BVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Bioventus
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Ticker
BVS
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Durham, United States
Employees
995
Website
www.bioventus.com
Bioventus Metrics
BasicAdvanced
$476M
Market cap
-
P/E ratio
-$0.34
EPS
0.63
Beta
-
Dividend rate
Price and volume
Market cap
$476M
Beta
0.63
Financial strength
Current ratio
1.534
Quick ratio
0.87
Long term debt to equity
172.599
Total debt to equity
191.279
Interest coverage (TTM)
0.50%
Management effectiveness
Return on assets (TTM)
1.52%
Return on equity (TTM)
-11.87%
Valuation
Price to revenue (TTM)
0.897
Price to book
2.76
Price to tangible book (TTM)
-1.54
Price to free cash flow (TTM)
229.153
Growth
Revenue change (TTM)
1.72%
Earnings per share change (TTM)
-92.58%
3-year revenue growth (CAGR)
17.25%
3-year earnings per share growth (CAGR)
47.18%
What the Analysts think about Bioventus
Analyst Ratings
Majority rating from 3 analysts.
Bioventus Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$129M
-4.43%
Net income
-$4.5M
-25.00%
Profit margin
-3.47%
-21.67%
Bioventus Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.14
$0.05
$0.07
$0.07
-
Expected
-
-$0.02
$0.02
-$0.08
$0.07
Surprise
-
-350.00%
250.00%
-193.33%
-
Bioventus News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bioventus stock?
Bioventus (BVS) has a market cap of $476M as of July 26, 2024.
What is the P/E ratio for Bioventus stock?
The price to earnings (P/E) ratio for Bioventus (BVS) stock is 0 as of July 26, 2024.
Does Bioventus stock pay dividends?
No, Bioventus (BVS) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Bioventus dividend payment date?
Bioventus (BVS) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioventus?
Bioventus (BVS) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Bioventus stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.